Breakthrough Bleeding with Continuous Combined Oral Contraceptive Use

Expected Bleeding Pattern

Unscheduled spotting or bleeding is common during the first 3-6 months of extended or continuous combined hormonal contraceptive use, and this is the most frequent adverse effect of extended-cycle regimens, according to the Centers for Disease Control and Prevention 1, 2, 3.
The bleeding is generally not harmful and decreases with continued combined hormonal contraceptive use, as recommended by the Centers for Disease Control and Prevention 1, 2, 3.
The longer the duration of continuous hormones, the greater the number of unscheduled bleeding days initially, though the difference between 28-day and 49-day cycles is relatively small, as noted by the American Academy of Pediatrics 6.

Before initiating continuous COC use, provide counseling about potential changes in bleeding patterns during extended or continuous combined hormonal contraceptive use, as recommended by the Centers for Disease Control and Prevention 1, 2, 3.
Patients should understand that breakthrough bleeding is expected in the first several months and does not indicate contraceptive failure, according to the Centers for Disease Control and Prevention 1, 2, 3.

No intervention is needed unless bleeding is clinically concerning, and patients should continue the continuous regimen without interruption during the adaptation period, as recommended by the Centers for Disease Control and Prevention 1, 2, 3.
If an underlying gynecological problem is found, treat the condition or refer for care, according to the Centers for Disease Control and Prevention 1, 2, 3.
Cigarette smoking, sexually transmitted infections, pregnancy, and new pathologic uterine conditions can contribute to breakthrough bleeding, as noted by the Centers for Disease Control and Prevention 1, 2, 3.

If an underlying gynecological problem is not found and the woman wants treatment, advise the woman to discontinue combined hormonal contraceptive use for 3-4 consecutive days, as recommended by the Centers for Disease Control and Prevention 1, 2, 3.
A hormone-free interval is not recommended during the first 21 days of using the continuous or extended combined hormonal contraceptive method, and not more than once per month, as noted by the Centers for Disease Control and Prevention 1, 2, 3.
Changing to a COC with higher estrogen content may be considered as an alternative management strategy, as suggested by the American Academy of Pediatrics 5.
If unscheduled spotting or bleeding persists and the woman finds it unacceptable, counsel her on alternative contraceptive methods, and offer another method if it is desired, according to the Centers for Disease Control and Prevention 1, 2, 3.